• 1. Treatment of type 2 diabetes mellitus: Clinical studies have shown that tirzepatide can effectively improve insulin resistance, reduce fasting and postprandial blood glucose and glycated hemoglobin levels, providing an effective treatment option for type 2 diabetes.

  2. Weight management and obesity treatment: Clinical data indicate that tirzepatide has significant fat-reducing and weight-loss effects, which can reduce overall body weight and visceral fat, and is suitable for the treatment of overweight and obesity.

  3. Improvement of metabolic disorders: Tirzepatide can regulate blood lipid levels and improve metabolic abnormalities, helping to reduce the risk of cardiovascular and metabolic-related diseases.

  4. Improvement of fatty liver conditions: Relevant trials have verified that tirzepatide can reduce liver fat accumulation, which has positive intervention and improvement effects on non-alcoholic fatty liver disease.

  5. Mental health regulation: Preclinical and clinical exploratory studies show that tirzepatide possesses antidepressant and anxiolytic potential, showing promising application prospects for the adjuvant treatment of anxiety and depression.

• 
  

 Company Profile   

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.